Home › Gastrointestinal Stromal Tumors › North Carolina › Durham
Gastrointestinal Stromal Tumors clinical trials in Durham, NC
4 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, Durham
DESTINY-PANTUMOUR04
RecruitingObservational study
- Research Site, Durham
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
RecruitingPhase 2
- University of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
RecruitingPhase 1
- Duke University Medical Center, Durham
Gastrointestinal Stromal Tumors trials in other cities
- Miami, FL8 studies
- New York City, NY7 studies
- Boston, MA7 studies
- Houston, TX6 studies
- Philadelphia, PA6 studies
- San Diego, CA5 studies
- Nashville, TN5 studies
- Portland, OR5 studies
- Omaha, NE5 studies
- Chicago, IL4 studies
- Dallas, TX4 studies
- Ann Arbor, MI4 studies
Other studies in Durham
- Breast Cancer64 studies
- Cancer (all types)58 studies
- Non-Small Cell Lung Cancer39 studies
- Multiple Myeloma37 studies
- Acute Myeloid Leukemia33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Lung Cancer32 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Chronic Lymphocytic Leukemia27 studies
- Heart Failure26 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.